Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Double-Dose PegInterferon Alfa-2B with wieghtbased ribavirin improves response for interferon/ribavirin non-responders with hepatitis C: Final results of "RENEW"

Double-Dose PegInterferon Alfa-2B with wieghtbased ribavirin improves response for interferon/ribavirin non-responders with hepatitis C: Final results of "RENEW". Hepatology. 2005; vol. 42(No. 4):63A.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.